SCHEMBL4929308

SCHEMBL4929308

Nc1cc(Cl)cc(COc2c(Br)cc(C=CC(=O)O)cc2Br)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
GAA P10253 1/20 0.40
CYP3A4 P08684 1/20 0.35
ALDH1A1 P00352 2/20 0.35
AKR1C3 P42330 2/20 0.35
HTR1A P08908 1/20 0.35
HPGD P15428 1/20 0.35
HTR2C P28335 1/20 0.35
HSD17B10 Q99714 1/20 0.35
AKR1C2 P52895 1/20 0.35
APP P05067 1/20 0.34
THRA P10827 3/20 0.33
THRB P10828 3/20 0.33
PKM P14618 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
RECQL P46063 1/20 0.33
TNFRSF1A P19438 2/20 0.33
AKR1B10 O60218 1/20 0.33
MMP2 P08253 1/20 0.33
AKR1B1 P15121 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4929295 1.00 KDM4E (0.40) KDM4EGAACYP3A4ALDH1A1AKR1C3
SCHEMBL4348539 0.81 KDM4E (0.39) KDM4EGAAALDH1A1AKR1C3HTR1A
SCHEMBL4348547 0.81 KDM4E (0.39) KDM4EGAAALDH1A1AKR1C3HTR1A
SCHEMBL4351638 0.80 KDM4E (0.38) KDM4EGAAALDH1A1AKR1C3HTR1A
SCHEMBL4351645 0.80 KDM4E (0.38) KDM4EGAAALDH1A1AKR1C3HTR1A
SCHEMBL4345974 0.78 KDM4E (0.36) KDM4EGAAAPPTHRATHRB
SCHEMBL4345980 0.78 KDM4E (0.36) KDM4EGAAAPPTHRATHRB
SCHEMBL4895267 0.73 THRA (0.61) KDM4EGAAALDH1A1APPTHRA
SCHEMBL4895271 0.73 THRA (0.61) KDM4EGAAALDH1A1APPTHRA
SCHEMBL4897130 0.69 THRA (0.62) KDM4EALDH1A1APPTHRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221210-A1 Thyroid Receptor Agonists KARO BIO AB (SE) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221210-A1 Thyroid Receptor Agonists TSHR, TRHR, THRA KDM4E 1703/4885GAA 4551/4885CYP3A4 2057/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.